Literature DB >> 3437748

A comparison of pentobarbital, fentanyl-droperidol, ketamine-xylazine and ketamine-diazepam anesthesia in adult male rats.

S K Wixson1, W J White, H C Hughes, C M Lang, W K Marshall.   

Abstract

Proper use of anesthetics is of paramount importance for humane animal care. Current research trends show a greater reliance on rats for laboratory investigations. This study compared several dosages for four different drugs, (pentobarbital, fentanyl-droperidol, ketamine-xylazine and ketamine-diazepam) for use in the laboratory rat. Each drug was evaluated in respect to its onset, duration of effect, recovery, adverse effects and mortality. A quantitative assessment of the depth of anesthesia also was obtained for all dosages of each drug. Results showed that all tested dosages of pentobarbital, ketamine-xylazine and ketamine-diazepam were suitable anesthetics for use in the laboratory rat. Low dosages of fentanyl-droperidol (Innovar-Vet), however, appeared to produce a state known as neuroleptanalgesia as opposed to anesthesia seen with the other agents.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3437748

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  11 in total

1.  Evaluation of Analgesic Efficacy of Meloxicam and 2 Formulations of Buprenorphine after Laparotomy in Female Sprague-Dawley Rats.

Authors:  Elizabeth A Nunamaker; Julia L Goldman; Cynthia R Adams; Jeffrey D Fortman
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-08-09       Impact factor: 1.232

2.  Deleterious impact of a γ-aminobutyric acid type A receptor preferring general anesthetic when used in the presence of persistent inflammation.

Authors:  Kevin Boegel; Ferenc E Gyulai; Kerry K Moore; Michael S Gold
Journal:  Anesthesiology       Date:  2011-10       Impact factor: 7.892

3.  Effects of Late Coronary Artery Reperfusion on Left Ventricular Remodeling Persist for 10 Weeks After Experimental Rat Myocardial Infarction and Are Associated with Improved Survival.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1994       Impact factor: 2.300

4.  Pharmacokinetics of ketamine and xylazine in young and old Sprague-Dawley rats.

Authors:  Daphnée Veilleux-Lemieux; Aude Castel; Denise Carrier; Francis Beaudry; Pascal Vachon
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

5.  Molecular, anatomical, physiological, and behavioral studies of rats treated with buprenorphine after spinal cord injury.

Authors:  José M Santiago; Odrick Rosas; Aranza I Torrado; María M González; Priya O Kalyan-Masih; Jorge D Miranda
Journal:  J Neurotrauma       Date:  2009-10       Impact factor: 5.269

6.  Oleuropein attenuates cognitive dysfunction and oxidative stress induced by some anesthetic drugs in the hippocampal area of rats.

Authors:  Masoud Alirezaei; Maryam Rezaei; Shahin Hajighahramani; Ali Sookhtehzari; Katayoun Kiani
Journal:  J Physiol Sci       Date:  2016-03-29       Impact factor: 2.781

7.  Effects of injectable anesthetic combinations on left ventricular function and cardiac morphology in Sprague-Dawley rats.

Authors:  Carla F Sabatini; M Lynne O'Sullivan; James E Valcour; William Sears; Ron J Johnson
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-01       Impact factor: 1.232

8.  The parasympatholytic effects of atropine sulfate and glycopyrrolate in rats and rabbits.

Authors:  M E Olson; D Vizzutti; D W Morck; A K Cox
Journal:  Can J Vet Res       Date:  1994-10       Impact factor: 1.310

9.  Ischemia-reperfusion injury of adipofascial tissue: an experimental study evaluating early histologic and biochemical alterations in rats.

Authors:  Yusuf Kenan Coban; Ergul Belge Kurutas; Harun Ciralik
Journal:  Mediators Inflamm       Date:  2005-10-24       Impact factor: 4.711

10.  Effects of endotoxemia on the pharmacodynamics and pharmacokinetics of ketamine and xylazine anesthesia in Sprague-Dawley rats.

Authors:  Daphnée Veilleux-Lemieux; Francis Beaudry; Pierre Hélie; Pascal Vachon
Journal:  Vet Med (Auckl)       Date:  2012-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.